Comparison
21q22 11q22 12 Microdeletion Syndrome C5192593 vs 16p13 11 Microdeletion Syndrome C4304596
Clinical comparison between 21q22 11q22 12 Microdeletion Syndrome and 16p13 11 Microdeletion Syndrome for differential diagnosis and treatment planning.
21q22 11q22 12 Microdeletion Syndrome C5192593
A rare genetic condition involving deletion of a specific region on chromosome 21. It may cause developmental delay, intellectual disability, and distinctive facial features. Management focuses on developmental support and medical monitoring.
16p13 11 Microdeletion Syndrome C4304596
A rare chromosomal deletion where a portion of chromosome 16 is missing. It may be associated with developmental delays, intellectual disability, and sometimes congenital anomalies. Management focuses on supportive care and addressing individual needs.
6 comparison axes
Onset
21q22 11q22 12 Microdeletion Syndrome C5192593
0-0
16p13 11 Microdeletion Syndrome C4304596
0-null
Onset patterns differ
Severity
21q22 11q22 12 Microdeletion Syndrome C5192593
severe
16p13 11 Microdeletion Syndrome C4304596
moderate
Different severity levels
Chronic
21q22 11q22 12 Microdeletion Syndrome C5192593
Chronic
16p13 11 Microdeletion Syndrome C4304596
Chronic
Differing course
Communicable
21q22 11q22 12 Microdeletion Syndrome C5192593
No
16p13 11 Microdeletion Syndrome C4304596
No
Different transmission
Body System
21q22 11q22 12 Microdeletion Syndrome C5192593
congenital
16p13 11 Microdeletion Syndrome C4304596
congenital
Same/different system
Category
21q22 11q22 12 Microdeletion Syndrome C5192593
rare-disease
16p13 11 Microdeletion Syndrome C4304596
genetic
Different category
Bottom line
21q22-11q22-12-microdeletion-syndrome-C5192593 and 16p13-11-microdeletion-syndrome-C4304596 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 16p13 11 Microdeletion Syndrome C4304596 | Discriminating power |
|---|---|---|---|
| Developmental delay | May occur in this severe congenital syndrome. | May occur within a moderate-severity spectrum. | Low |
| Intellectual disability | Possible; individual severity is not established here. | Possible; individual severity is not established here. | Low |
| Physical features | Distinctive facial features may be present. | Congenital anomalies are sometimes reported, without specifics here. | Moderate |
When to favor each condition
Choose 21q22 11q22 12 Microdeletion Syndrome C5192593 when
Testing shows a 21q22.11-q22.12 deletion
The chromosome 21 locus defines this condition.
High
Severe congenital presentation with facial features
This matches the supplied severity and feature description, but is not definitive alone.
Moderate
Counseling concerns a chromosome 21 microdeletion
Support is individualized, while the genetic locus differs.
High
Choose 16p13 11 Microdeletion Syndrome C4304596 when
Testing shows a 16p13.11 deletion
The chromosome 16 locus defines this condition.
High
Moderate developmental presentation with variable anomalies
This aligns with the supplied moderate severity and possible anomalies.
Moderate
Onset timing is incompletely documented
The supplied onset for this condition is not fully specified.
Low
How key tests differ
| Test | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 16p13 11 Microdeletion Syndrome C4304596 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Deletion involving 21q22.11-q22.12 if confirmed. | Deletion involving 16p13.11 if confirmed. | Locus distinguishes them; clinical features alone do not. |
| Dysmorphology examination | May identify distinctive facial features. | May identify variable congenital anomalies. | Findings are nonspecific and need specialist interpretation. |
| Developmental assessment | May document delay or intellectual disability. | May document delay or intellectual disability. | Similar possible results do not establish either diagnosis. |
Prognosis comparison
21q22 11q22 12 Microdeletion Syndrome C5192593
- Outcome
- Described as severe and chronic, but individual outcome is not established.
- Factors
- Developmental progress, facial or medical findings, and support access.
16p13 11 Microdeletion Syndrome C4304596
- Outcome
- Described as moderate and chronic, with variable needs.
- Factors
- Developmental findings, congenital anomalies, and supportive services.
Time frame: Lifelong from early life; precise course is not established.
Confirmed locus, associated findings, developmental trajectory, and care access.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Support needs may be substantial. Support needs may vary. Exact functional impact is not established. |
| Learning support | Intellectual disability may require ongoing education support. Intellectual disability may require individualized learning support. Severity for a person cannot be inferred from these labels. |
| Medical monitoring | Monitoring is recommended for associated needs. Monitoring addresses individual anomalies when present. No specific complication rate is supplied. |
Patient education highlights
- HighGenetic confirmation
Ask a genetics clinician to confirm the exact deleted region before relying on either label.
- HighSupportive care
Care focuses on development, learning, and individual medical needs; no dose or treatment protocol is established here.
- MediumTransmission
Neither condition is communicable. Inheritance and family testing require genetics counseling.